IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q1 2015 Holdings

Filed 2015-05-11 | 19 holdings | $36.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$35.4M3,608,17198.0%
Esperion Therapeutics Inc(ESPR)COM29664W105$190.3K2,054,5940.5%
Cempra IncCOM15130J109$113.0K3,293,0600.3%
Zeltiq Aesthetics IncCOM98933Q108$80.1K2,597,7420.2%
Loxo Oncology IncCOM548862101$43.0K3,452,4930.1%
Versartis IncCOM92529L102$41.9K2,279,5680.1%
T2 Biosystems IncCOM89853L104$39.2K2,523,3000.1%
Chimerix Inc(CMRXEUR)COM16934W106$38.6K1,022,9430.1%
Catalent Inc(CTLTEUR)COM148806102$34.5K1,106,7290.1%
Agile Therapeutics Inc(AGRXUSD)COM00847L100$27.7K2,983,7970.1%
TransEnterix IncCOM NEW89366M201$24.4K8,335,8190.1%
Pernix Therapeutics Hldgs inCOM71426V108$21.5K2,010,0000.1%
Paratek Pharmaceuticals, Inc.COM699374302$21.3K682,6800.1%
Sorrento Therapeutics Inc(SRNE)COM NEW83587F202$20.4K1,763,5000.1%
Dermira Inc.(DERMEUR)COM24983L104$16.9K1,102,0460.0%
Intersect ENT IncCOM46071F103$9.0K350,0000.0%
Roka Bioscience IncCOM775431109$3.6K1,122,4170.0%
Lombard MED IncCOMG55598109$3.6K886,3630.0%
MEI Pharma IncCOM NEW55279B202$000.0%